Whitehawk Therapeutics, Inc. Share Price

Whitehawk Therapeutics, Inc. Share Price

NASDAQ: WHWK | Micro Cap
$3.30
-$0.15 (-4.21%) Last updated on 30 Oct, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Whitehawk Therapeutics, Inc. Stock Performance

Open
$3.51
Prev. Close
$3.44
Circuit Range
N/A
Day Range
$3.25 - $3.51
Year Range
$1.97 - $5.47
Volume
32,432
Average Traded
$3.35

Whitehawk Therapeutics, Inc. Share Price Today

As of 30 October 2026, Whitehawk Therapeutics, Inc.'s share price is $3.30. The stock opened at $3.51, compared to its previous close of $3.44. During today's trading session, Whitehawk Therapeutics, Inc.'s share price traded between $3.25 and $3.51, with an average price of $3.38. Over the past 52 weeks, the stock has recorded a high of $5.47 and a low of $1.97. In terms of performance, Whitehawk Therapeutics, Inc.'s share price has declined by 17.79% over the last six months and is up 38.66% on a year-on-year basis.

Whitehawk Therapeutics, Inc. Share Price Chart

Line chart of the Whitehawk Therapeutics, Inc. price trend over the selected period. The price fell overall, ranging from 3.25 to 3.51, ending at 3.30.
$3.25$3.51
L
Show Current Price
H

Whitehawk Therapeutics, Inc. Stock Fundamentals & Key Indicators

Market Cap
$204.23M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-1.40
Revenue (TTM)
$7.15B
Return On Equity (TTM)
-43.64%
Profit Margin
-288.11%
Debt to Equity
0.00
Quarterly Earnings Growth YoY
5.56%

Whitehawk Therapeutics, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$0.00$0.00$0.00$0.00
Net Profit-$17.62-$23.37-$22.19-$16.64
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A-32.63%5.05%25.01%

Whitehawk Therapeutics, Inc. Annual Profit & Loss

All figures in USD

Particulars2025
Revenue$7.15
Net Profit-$20.60
Net Profit Margin-288.11%
Income ChangeN/A

About Whitehawk Therapeutics, Inc.

Whitehawk Therapeutics Inc is an oncology therapeutics company applying technologies to tumor biology to develop cancer treatments. Its portfolio includes three antibody-drug conjugate (ADC) candidates designed to address limitations of earlier therapies for patients with difficult-to-treat cancers. The company generates revenue from the sale of its products.

Whitehawk Therapeutics, Inc. Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Oct 2026
$3.85
$3.29
-12.13%
Sep 2026
$4.66
$3.75
-23.00%
Aug 2026
$3.82
$4.87
+26.49%
Jul 2026
$4.58
$3.85
-15.75%
Jun 2026
$4.76
$4.57
-3.18%
May 2026
$4.01
$4.72
+17.59%
Apr 2026
$3.48
$4.01
+16.69%
Mar 2026
$3.40
$3.44
-1.99%
Feb 2026
$2.76
$3.51
+30.00%
Jan 2026
$2.39
$2.70
+11.34%
Dec 2025
$2.27
$2.42
+3.63%
Nov 2025
$2.35
$2.34
-1.68%

WHWK Share Price FAQs